HanaVax Inc. is elected as a ‘Final 10’ from Japan, will participate in ‘London Demo Day (Nov 21 & 22)’; a global pitch event organized by MRI and Oxentia, Ltd.
HanaVax Inc. and YISHENG BIOPHARMA CO., LTD. developing novel pneumococcal vaccine for China
President & CEO; Pohsing Ng; will participate in BIO International Convention 2019 at Philadelphia (Jun 3-6). Company presentation will be scheduled on Jun 3 (Mon) 4:45PM at Theater 2. During the partnering session; HanaVax is also looking forward to meeting with Pharma and VC showing interest in our platform technologies and lead product.
HanaVax Inc. co-founders Hiroshi Kiyono will give a keynote presentation at The 120th Annual Meeting of the ORL Society of Japan (May 9, 2019).
HanaVax Inc. President & CEO Pohsing Ng will attend BIO Asia International Conference 2019 (March 5-6, 2019) and Company Presentation scheduled at Mar 6; 1030-1045.